Epstein-Barr Virus Research - EBV, Infectious Mononucleosis, Glandular Fever, Chronic Fatigue

Epstein-Barr Virus Research Today is a free monthly online journal that collates and summarizes the latest research about Epstein-Barr Virus, including details on ebv, infectious mononucleosis, glandular fever, chronic fatigue.


Epstein-Barr Virus Research Today

Home

View Latest Issue

Information About Epstein-Barr Virus

Books on Epstein-Barr Virus

Advertising in Research Today

View Other Research Today Publications



Volume 4 (2008), Issue 4 (April)

  1. Epstein Barr virus induced lymphoma in a child with IPEX syndrome.
    Pediatr Blood Cancer, 50(5): 1056-7. [Abstract] [Full-text]
  2. Reactive nitrogen species-dependent DNA damage in EBV-associated nasopharyngeal carcinoma: the relation to STAT3 activation and EGFR expression.
    Int J Cancer, 122(11): 2517-25. [Abstract] [Full-text]
  3. Combined proteasome and Bcl-2 inhibition stimulates apoptosis and inhibits growth in EBV-transformed lymphocytes: a potential therapeutic approach to EBV-associated lymphoproliferative diseases.
    Eur J Haematol, 80(5): 407-18. [Abstract] [Full-text]
  4. Interleukin-21 regulates expression of key Epstein-Barr virus oncoproteins, EBNA2 and LMP1, in infected human B cells.
    Virology, 374(1): 100-13. [Abstract] [Full-text]
  5. Antibodies against Epstein-Barr virus gp78 antigen: a novel marker for serological diagnosis of nasopharyngeal carcinoma detected by xMAP technology.
    J Gen Virol, 89: 1152-8. [Abstract] [Full-text]
  6. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Autoimmunity, 41(4): 298-328. [Abstract] [Full-text]
  7. Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virus-infected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors.
    J Virol, 82(10): 4706-19. [Abstract] [Full-text]
  8. Inhibitory effects of some derivatives of glycyrrhizic acid against Epstein-Barr virus infection: structure-activity relationships.
    Antiviral Res, 79(1): 6-11. [Abstract] [Full-text]
  9. Human cytomegalovirus and Epstein-Barr virus in apical and marginal periodontitis: a role in pathology?
    J Med Virol, 80(6): 1007-11. [Abstract] [Full-text]
Place a permanent text-link or advertisement here for just US$15.

© 2005-2008 Epstein-Barr Virus Research Today. All Rights Reserved.



Epstein-Barr Virus Research Today Archive:

Volume 1 (2005)
  Issue 1 (November)
  Issue 2 (December)

Volume 2 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)



Epstein-Barr Virus Books

Epstein-Barr Virus and Kaposi's Sarcoma Herpes Virus/Human Herpesvirus 8 (IARC Monographs on Eval of Carcinogenic Risk to Humans)

Epstein-Barr Virus and Kaposi's Sarcoma Herpes Virus/Human Herpesvirus 8 (IARC Monographs on Eval of Carcinogenic Risk to Humans)